Bill dał na początku zarazy 100 mln. dla WHO Genewie, aby uzyskać przywileje./
Następnie zlecił wyprodukowanie szczepionki z osocza zarażonych Hindusow w Indiach, aby zarobić 100%
I przyjechała wadliwa Astra Zeneca do Europy, Polski i byla rekomendowana przez ministra zdrowia, a była wadliwa, wywoływala paraliże, zakrzepice, zgony
i 4 ministrów zdrowia z zachodniej Europy zakazało jej stosowania, a w Polsce dalej b yla polecana.
W Mimcach tysiące pozwów o odszkodoania za wadliwa Astra Zeneca, a w Polsce temat zamieciono pod dywan i usunięto z mediów i Mimce dostana miliardy odszkodowania za utrate zdrowia, zgony,
a Polacy dostaną jak zwykle, czyli psinco
Żona Billa uciekła z kasą, obawiając się odszkodowań, czyli rozwiodła się, aby uratować kasę.
Czy Polacy to podludzie i odszkodowania się im nie należą ?
Tutaj zgony na Astra Zeneca z hamerykanskiej bazy z interfejsem
Roberta Kennedy'ego, juniora
\
I każdy może sam sprawdzic ilu zmarło w Hameryce po zaszczepieniu Astra Zenecą
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=on&PAGENO=3585&PERPAGE=10&ESORT=&REVERSESORT=&VAX=(COVID19)&DIED=Yes
Tutaj są pelne kartoteki pacjentów, którzy zmarli w wyniku zaszczepienia na covida
////
Astra Zeneca pojawia się jako przyczyna zgonu wcześniej, bo potem została zutylizowana
Search Results
From the 9/8/2023 release of VAERS data:
Found 35,843 cases where Vaccine is COVID19 and Patient Died
Government Disclaimer on use of this data
Case Details
This is page 3585 out of 3,585
Result pages: prev 3576 3577 3578 3579 3580 3581 3582 3583 3584 3585
VAERS ID: 2680128 (history)
Form: Version 2.0
Age: 60.0
Sex: Female
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2023-09-07
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT
Administered by: Other Purchased by: ?
Symptoms: Incorrect route of product administration, Ischaemic stroke
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Drug abuse and dependence (broad), Medication errors (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CAPFIZER INC202300294245
Write-up: Subcutaneous route of administration; Ischaemic stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority. Regulatory number: (RA). A 60-year-old female patient received
BNT162b2, BNT162b2 omi ba.4-5 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) at the age of 60 years subcutaneous for covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported.
The following information was reported: ISCHAEMIC STROKE (death), outcome "fatal"; INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "Subcutaneous route of administration". The date and cause of death for the
patient were unknown. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death
VAERS ID: 2680186 (history)
Form: Version 2.0
Age: 67.0
Sex: Female
Location: Foreign
Vaccinated: 2022-11-12
Onset: 2022-11-01
Submitted: 0000-00-00
Entered: 2023-09-07
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH GD6800 / 4 RA / OT
Administered by: Other Purchased by: ?
Symptoms: Acute kidney injury, Alanine aminotransferase, Asthenia, Atelectasis, Autoimmune hepatitis, Blood alkaline phosphatase, Blood creatine phosphokinase, Blood pressure measurement, Bronchial secretion retention, Burning sensation, Dyspnoea, Gait
disturbance, Gamma-glutamyltransferase, Heart rate, Immobile, Metabolic acidosis, Muscle spasms, Muscular weakness, Myositis, Pain in extremity, Protein urine, Renal tubular necrosis, Respiratory rate, Rhabdomyolysis
SMQs:, Rhabdomyolysis/myopathy (narrow), Acute renal failure (narrow), Hepatitis, non-infectious (narrow), Anaphylactic reaction (broad), Lactic acidosis (broad), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad),
Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad),
Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dystonia (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Pulmonary
hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (broad), Renovascular disorders (broad), Chronic kidney disease (broad), Tumour lysis syndrome (narrow), Proteinuria (narrow),
Tubulointerstitial diseases (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad), Immune-mediated/
autoimmune disorders (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2022-11-23
Days after onset: 22
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2680191 (history)
Form: Version 2.0
Age: 76.0
Sex: Male
Location: Foreign
Vaccinated: 2021-07-27
Onset: 2021-08-10
Days after vaccination: 14
Submitted: 0000-00-00
Entered: 2023-09-07
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY0572 / 2 - / -
Administered by: Other Purchased by: ?
Symptoms: Body temperature, Fall, Guillain-Barre syndrome, Injury, Interstitial lung disease, Pneumonia aspiration, Weight decreased
SMQs:, Peripheral neuropathy (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Interstitial lung disease (narrow), Guillain-Barre syndrome (narrow), Accidents and injuries (narrow), Hostility/aggression (broad), Demyelination (narrow),
Eosinophilic pneumonia (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2021-10-02
Days after onset: 53
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: body temperature; Result Unstructured Data: Test Result:36.0 Centigrade; Comments: before vaccination
CDC Split Type: JPPFIZER INCPV20230014978
Write-up: Guillain-Barre syndrome; Interstitial pneumonia; pneumonia aspiration; fell when he moved around at home, breaking the glass and having an injury on his arm; fell when he moved around at home, breaking the glass and having an injury on his arm;
thin in body because he rapidly lost weight; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority. Regulatory number: (RA). A 76-year-7-month-old male patient received BNT162b2 (
COMIRNATY), on 27Jul2021 at 10:30 as dose 2, single (Lot number: EY0572, Expiration Date: 31Oct2021) at the age of 76 years for covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported. Vaccination
history included: comirnaty (DOSE 1, SINGLE, Lot number: EY5422; , Expiration date: 31Aug2021.), administration date: 06Jul2021, for COVID-19 immunisation, reaction(s): "malaise". Body temperature before vaccination was 36.0 degrees Centigrade. The
patient had no family history. The points to be considered on the vaccine screening questionnaire (primary diseases, allergies, vaccinations, and illnesses within the last one month, medications the patient was taking, past adverse effect history, growth
status) included: the first dose of BNT162b2. On 10Aug2021 at 10:30 am (14 days after the vaccination), the patient experienced Guillain-Barre syndrome and Interstitial pneumonia. On 02Oct2021 (67 days after the vaccination), the outcome of events(
Guillain-Barre syndrome and Interstitial pneumonia) was fatal. The course of the event was as follows: approximately 10 days after the 2nd vaccination, the patient complained of pain, numbness, and feelings of weakness from the right thigh to the entire
right leg. Gradually, it became difficult for him to stand up and walk by himself, and an application for the certification of nursing care was made. At the same time, although he was moved from hospital to hospital, the cause was unknown. The feelings
of weakness expanded to all the extremities, which made it difficult for him to operate the smartphone. Approximately one month after the vaccination, the patient was admitted to the hospital to undergo tests, which were indicative of acute Guillain-
Barre syndrome (multiple neuritis). At the request of the patient himself, he was discharged from the hospital. Three days later, the patient was admitted to the hospital for rehabilitation and treatment. However, the autoimmune was rapidly decreased and
on 01Oct of the same year, the patient was in critical condition. The next day, the patient ended his life at the age of 76 years because of pneumonia aspiration. The reporter classified the events (Guillain-Barre syndrome and Interstitial pneumonia) as
serious (death) and assessed that events (Guillain-Barre syndrome and Interstitial pneumonia) as related to the vaccine. There was no other possible cause of the event such as any other diseases. Additionally described clinical symptoms included:
bilateral and flaccid muscular weakness in the upper or lower limbs (date of onset: 10Aug2021), decreased or lost deep tendon reflex in the upper or lower limbs with muscular weakness. Hughes Functional Grading Scale scores in the worst phase of disease
until this report was selected as "6: death". Disease showing a monophasic pathological pattern with the interval of 12 hours to 28 days between the onset of muscular weakness and the nadir, followed by clinically stable phase. Electrophysiological study
was unknown. Cerebrospinal fluid test was unknown. Differential diagnosis, as other diseases including those listed on the Appendix table were excluded. Imaging examination (Magnetic resonance imaging (MRI)) was unknown. Autoantibody test was unknown.
Preceding infection was noted as none. The reporter commented that the patient was father to the reporter. Before the vaccination, he was healthy enough to go shopping on foot and bring back the heavy baggage. While he was complaining of arm 1 and
malaise after the 1st vaccination, he received the 2nd vaccination three weeks later. Ten days thereafter, he started complaining of pain and numbness, and eventually became unable to go to the toilet by himself. In his work, he was soon unable to walk,
an application for the certification of nursing care was made. During that time, since he had to go out, he purchased a wheelchair at actual cost. He fell when he moved around at home (dates unspecified), breaking the glass and having an injury on his
arm, etc. Reporter was told at the university hospital that acute Guillain-Barre syndrome was suspected. The reporter noted suspicion at first of the vaccine, based on the symptoms and the onset timing. Physicians did not rule it out, but not proactively.
Patient was admitted again to a hospital near his house to undergo rehabilitation and hospitalized treatment. For three days after discharge, he was almost bedridden. The patient was thin in body because he rapidly lost weight. Even at the hospital
where he was transferred, reporter noted that it was proactively recognized that the vaccine was the cause. The reporter noted that the patient died of pneumonia aspiration; reporter also noted that if he had not received the vaccine and developed
Guillain-Barre syndrome, he would not have died. Per the reporter, even though Guillain-Barre syndrome is a serious post-vaccination adverse reaction, the hospitals did not submit a report to PMDA. Reporter noted that there was bias depending on local
governments, hospitals, and physicians.; Sender''s Comments: Linked Report(s) : JP-PFIZER INC-202300293009 same reporter/product/patient ,different dose/event;; Reported Cause(s) of Death: pneumonia aspiration; Guillain-Barre syndrome; Interstitial
pneumonia
Result pages: prev 3576 3577 3578 3579 3580 3581 3582 3583 3584 3585
New Search
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3585&VAX=COVID19&DIED=Yes
Copyright © 2023 National Vaccine Information Center. All rights reserved. 21525 Ridgetop Circle, Suite 100, Sterling, VA 20166
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)